Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation

Journal of the Neurological Sciences

Volumn 268, Issue 1-2, 2008, Pages 124-130

  Lindquist, Suzanne Granhøj ^a,b   Nielsen, Jørgen Erik ^a,b   Stokholm, Jette ^a   Schwartz, Marianne ^a   Batbayli, Mustafa ^a   Ballegaard, Martin ^a   Erdal, Jesper ^a   Krabbe, Katja ^c   Waldemar, Gunhild ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MR Department   (Denmark)

Author keywords

Alzheimer's disease; Amyloid precursor protein gene; Autonomic failure; Autosomal dominant; Complex partial seizures; Genetics; Phenotype

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTICONVULSIVE AGENT; CITALOPRAM; DONEPEZIL; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXCARBAZEPINE; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; AMNESIA; ARTICLE; AUTONOMIC DYSFUNCTION; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DEMENTIA; DEPRESSION; DISEASE COURSE; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HUMAN; LABORATORY TEST; MALE; MISSENSE MUTATION; MORTALITY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATIC EPILEPSY; VITAL SIGN;

ALANINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BLOOD PRESSURE; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; FAMILY HEALTH; HUMANS; IRAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PEPTIDE FRAGMENTS; THREONINE;

EID: 40849116359     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.11.021     Document Type: Article

References (18)

1. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 6311 (1991) 704-706
2. http://www.molgen.ua.ac.be/ADMutations/.
3. Crook R., Verkkoniemi A., Perez-Tur J., Mehta N., Baker M., Houlden H., et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4 4 (1998) 452-455
4. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerrière A., Vital A., et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38 1 (2006) 24-26
5. Stokholm J., Jakobsen O., Czarna J.M., Mortensen H.V., and Waldemar G. Years of severe and isolated amnesia can precede the development of dementia in early-onset Alzheimer's disease. Neurocase 11 1 (2005) 48-55
6. Wieling W., and Karemaker J.M. In: Mathias C.J., and Bannister R. (Eds). Autonomic failure: a textbook of clinical disorders of the autonomic nervous system (1999), Oxford University Press, Oxford
7. Mendez M., and Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 20 11 (2003) 791-803
8. Chen J.Y., Stern Y., Sano M., and Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 48 11 (1991) 1141-1143
9. Larner A.J., and Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 253 2 (2006) 139-158
10. Pasalar P., Najmabadi H., Noorian A.R., Moghimi B., Jannati A., Soltanzadeh A., et al. An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala). Neurology 58 10 (2002) 1574-1575
11. Zekanowski C., Styczynska M., Peplonska B., Gabryelewicz T., Religa D., Ilkowski J., et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Exp Neurol 184 2 (2003) 991-996
12. Perry E.K., Haroutunian V., Davis K.L., Levy R., Lantos P., Eagger S., et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 5 7 (1994) 747-749
13. Wang S.J., Liao K.K., Fuh J.L., Lin K.N., Wu Z.A., Liu C.Y., et al. Cardiovascular autonomic functions in Alzheimer's disease. Age Ageing 23 5 (1994) 400-404
14. Allan L.M., Kerr S.R., Ballard C.G., Allen J., Murray A., McLaren A.T., et al. Autonomic function assessed by heart rate variability is normal in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 19 2-3 (2005) 140-144
15. Allan L.M., Ballard C.G., Allen J., Murray A., Davidson A.W., McKeith I.G., et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 78 7 (2007) 671-677
16. Ewing D.J., Martyn C.N., Young R.J., and Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 5 (1985) 491-498
17. Aharon-Peretz J., Harel T., Revach M., and Ben-Haim S.A. Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease. Arch Neurol 49 9 (1992) 919-922
18. Royall D.R., Gao J.H., and Kellogg Jr. D.L. Insular Alzheimer's disease pathology as a cause of "age-related" autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses 67 4 (2006) 747-758